Literature DB >> 646346

In vitro response to chloramphenicol, tetracycline, ampicillin, gentamicin, and beta-lactamase production by halophilic Vibrios from human and environmental sources.

S W Joseph, R M DeBell, W P Brown.   

Abstract

Isolates of Vibrio parahaemolyticus and V. alginolyticus from human and environmental sources were examined for antibiotic susceptibility by the methods of minimal inhibitory concentration (MIC) in broth and agar diffusion. These strains were found to be almost uniformly susceptible to chloramphenicol and tetracycline within attainable serum levels. The relationships of zone sizes to MICs for these two antimicrobial agents and ampicillin conformed essentially to those obtained by standard methods with gram-negative rods. Most strains were resistant to ampicillin and exhibited beta-lactamase activity, which accounted for this resistance. Nine of 30 V. alginolyticus strains from environmental sources were ampicillin resistant but did not produce measurable amounts of beta-lactamase. Three strains exhibited multiresistance to high concentrations of chloramphenicol, tetracycline, and ampicillin, which suggests the presence of plasmids. Although the great majority of vibrios appeared to be susceptible to gentamicin by agar diffusion, susceptibility could not be measured by MIC because the added NaCl, required for growth by the halophilic vibrios, diminished gentamicin activity.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 646346      PMCID: PMC352221          DOI: 10.1128/AAC.13.2.244

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  8 in total

1.  Isolation of Vibrio alginolyticus from wound infections.

Authors:  S J Rubin; R C Tilton
Journal:  J Clin Microbiol       Date:  1975-12       Impact factor: 5.948

2.  Iodometric assay of penicillinase.

Authors:  C J PERRET
Journal:  Nature       Date:  1954-11-27       Impact factor: 49.962

3.  Clinical manifestations of halophilic non-cholera Vibrio infections.

Authors:  S B Thorsteinsson; J N Minuth; D M Musher
Journal:  Lancet       Date:  1974-11-30       Impact factor: 79.321

4.  Halophilic vibrios from extraintestinal lesions in man.

Authors:  A von Graevenitz; G O Carrington
Journal:  Infection       Date:  1973       Impact factor: 3.553

5.  The evolution of r factor. A study of a "preantibiotic" community in Borneo.

Authors:  C E Davis; J Anandan
Journal:  N Engl J Med       Date:  1970-01-15       Impact factor: 91.245

6.  Activity of penicillinase in Staphylococcus aureus as studied by the iodometric method.

Authors:  R G Workman; W E Farrar
Journal:  J Infect Dis       Date:  1970-04       Impact factor: 5.226

7.  Antibiotic susceptibility testing by a standardized single disk method.

Authors:  A W Bauer; W M Kirby; J C Sherris; M Turck
Journal:  Am J Clin Pathol       Date:  1966-04       Impact factor: 2.493

8.  Halophilic Vibrio species isolated from blood cultures.

Authors:  D G Hollis; R E Weaver; C N Baker; C Thornsberry
Journal:  J Clin Microbiol       Date:  1976-04       Impact factor: 5.948

  8 in total
  12 in total

1.  Sequence analysis of the gyrA and parC homologues of a wild-type strain of Vibrio parahaemolyticus and its fluoroquinolone-resistant mutants.

Authors:  J Okuda; E Hayakawa; M Nishibuchi; T Nishino
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

2.  Two strains of Vibrio species with unusual biochemical features isolated from ear tracts.

Authors:  W Hansen; F Crokaert; E Yourassowsky
Journal:  J Clin Microbiol       Date:  1979-01       Impact factor: 5.948

3.  Aeromonas primary wound infection of a diver in polluted waters.

Authors:  S W Joseph; O P Daily; W S Hunt; R J Seidler; D A Allen; R R Colwell
Journal:  J Clin Microbiol       Date:  1979-07       Impact factor: 5.948

Review 4.  Current perspectives on the epidemiology and pathogenesis of clinically significant Vibrio spp.

Authors:  J M Janda; C Powers; R G Bryant; S L Abbott
Journal:  Clin Microbiol Rev       Date:  1988-07       Impact factor: 26.132

5.  Association of Aeromonas sobria with human infection.

Authors:  O P Daily; S W Joseph; J C Coolbaugh; R I Walker; B R Merrell; D M Rollins; R J Seidler; R R Colwell; C R Lissner
Journal:  J Clin Microbiol       Date:  1981-04       Impact factor: 5.948

6.  Necrotizing fasciitis due to Vibrio alginolyticus in an immunocompetent patient.

Authors:  Juan M Gomez; Roosevelt Fajardo; Jose F Patiño; Cesar A Arias
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

7.  Antimicrobial susceptibilities of Vibrio parahaemolyticus and Vibrio vulnificus isolates from Louisiana Gulf and retail raw oysters.

Authors:  Feifei Han; Robert D Walker; Marlene E Janes; Witoon Prinyawiwatkul; Beilei Ge
Journal:  Appl Environ Microbiol       Date:  2007-09-07       Impact factor: 4.792

8.  Characterization and distribution of Vibrio alginolyticus and Vibrio parahaemolyticus isolated in Indonesia.

Authors:  E Molitoris; S W Joseph; M I Krichevsky; W Sindhuhardja; R R Colwell
Journal:  Appl Environ Microbiol       Date:  1985-12       Impact factor: 4.792

Review 9.  Fatal Vibrio parahemolyticus septicemia in a patient with cirrhosis. A case report and review of the literature.

Authors:  R J Hally; R A Rubin; H S Fraimow; M L Hoffman-Terry
Journal:  Dig Dis Sci       Date:  1995-06       Impact factor: 3.199

10.  Septic shock due to Vibrio alginolyticus in a cirrhotic patient: the first case in Korea.

Authors:  Dong-Young Lee; Soo-Youn Moon; Sang-Oh Lee; Hee-Young Yang; Hee-Joo Lee; Mi Suk Lee
Journal:  Yonsei Med J       Date:  2008-04-30       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.